BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11817337)

  • 1. CCK stimulates growth of both the pancreas and the liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
    Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devazepide-induced hyperplasia in the rat liver and bile ducts.
    Ohlsson B; Axelson J; Rehfeld JF; Ihse I
    Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
    Wu XM; Liao YW; Ji KQ; Li GF; Zang B
    J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
    Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
    Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells.
    Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M
    Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
    Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S; Coleman FH; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine.
    Nylander AG; Chen D; Ding XQ; Norlén P; Håkanson R
    Pharmacol Toxicol; 1997 Mar; 80(3):142-6. PubMed ID: 9101587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-8-induced hypoplasia of the rat pancreas: influence of nitric oxide on cell proliferation and programmed cell death.
    Trulsson LM; Gasslander T; Svanvik J
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):183-90. PubMed ID: 15504154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
    González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
    J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.